Nutraceutical Int'l (NUTR) Earning Favorable Media Coverage, Study Shows

News stories about Nutraceutical Int'l (NASDAQ:NUTR) have trended positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nutraceutical Int'l earned a daily sentiment score of 0.34 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.6567035316929 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of Nutraceutical Int'l (NASDAQ:NUTR) opened at $41.80 on Monday. Nutraceutical Int'l has a fifty-two week low of $24.92 and a fifty-two week high of $42.45. The company has a current ratio of 4.40, a quick ratio of 1.42 and a debt-to-equity ratio of 0.28. The stock has a market cap of $386.52, a price-to-earnings ratio of 26.97 and a beta of 0.48.

TRADEMARK VIOLATION NOTICE: “Nutraceutical Int'l (NUTR) Earning Favorable Media Coverage, Study Shows” was originally published by Equities Focus and is the sole property of of Equities Focus. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at

About Nutraceutical Int'l

Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.

Insider Buying and Selling by Quarter for Nutraceutical Int'l (NASDAQ:NUTR)

Receive News & Ratings for Nutraceutical Int'l Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical Int'l and related companies with's FREE daily email newsletter.

Leave a Reply